Insider Trading activities of Opiant Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Opiant Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Opiant Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Opiant Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is OPNT. The reporting company's CIK number is 1385508.
The total value of stock buying since 2005 is $82,450.
The total value of stock sales since 2005 is $5,568,118.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Opiant Pharmaceuticals, Inc. (OPNT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-12 0 $0 211,224 $4,782,168 0 $0
2017-01 11,795 $82,450 0 $0 0 $0
2015-01 0 $0 1,700 $5,950 0 $0
2009-07 0 $0 10,000,000 $780,000 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Opiant Pharmaceuticals, Inc. insiders (OPNT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-12-28 Wolf Geoffrey Sale 43,000 22.52 968,360
2017-12-27 Wolf Geoffrey Sale 37,850 21.51 814,153
2017-12-21 Wolf Geoffrey Sale 20,000 24.17 483,400
2017-12-20 Wolf Geoffrey Sale 69,016 22.75 1,570,114
2017-12-19 Wolf Geoffrey Sale 3,850 19.69 75,806
2017-12-18 Wolf Geoffrey Sale 27,134 20.68 561,131
2017-12-13 Wolf Geoffrey Sale 7,804 29.61 231,076
2017-12-08 Wolf Geoffrey Sale 2,570 30.40 78,128
2017-01-17 Crystal Roger (Chief Executive Officer) Buy 3,475 6.99 24,290
2017-01-17 Sinclair Michael (Executive Chairman) Buy 3,500 7.00 24,517
2017-01-13 Pollack Kevin (See Remarks) Buy 4,820 6.98 33,643
2015-01-15 Sinclair Michael (Executive Chairman) Sale 1,700 3.50 5,950
2009-07-31 Meuse Joseph J (Director) Sale 10,000,000 .08 780,000

Insider trading activities including stock purchases, stock sales, and option exercises of OPNT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Opiant Pharmaceuticals, Inc. (symbol OPNT, CIK number 1385508) see the Securities and Exchange Commission (SEC) website.